Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article (169)

Advertisement

Research Article Free access | 10.1172/JCI107825

Thyroid Hormone Action IN VITRO CHARACTERIZATION OF SOLUBILIZED NUCLEAR RECEPTORS FROM RAT LIVER AND CULTURED GH1 CELLS

Herbert H. Samuels, Jir S. Tsai, Juan Casanova, and Frederick Stanley

1Endocrine Division, Department of Medicine, New York University Medical Center, New York 10016

Find articles by Samuels, H. in: PubMed | Google Scholar

1Endocrine Division, Department of Medicine, New York University Medical Center, New York 10016

Find articles by Tsai, J. in: PubMed | Google Scholar

1Endocrine Division, Department of Medicine, New York University Medical Center, New York 10016

Find articles by Casanova, J. in: PubMed | Google Scholar

1Endocrine Division, Department of Medicine, New York University Medical Center, New York 10016

Find articles by Stanley, F. in: PubMed | Google Scholar

Published October 1, 1974 - More info

Published in Volume 54, Issue 4 on October 1, 1974
J Clin Invest. 1974;54(4):853–865. https://doi.org/10.1172/JCI107825.
© 1974 The American Society for Clinical Investigation
Published October 1, 1974 - Version history
View PDF
Abstract

We previously reported that putative nuclear receptors for thyroid hormone can be demonstrated by incubation of hormone either with intact GH1 cells, a rat pituitary tumor cell line, or with isolated GH1 cell nuclei and rat liver nuclei in vitro.

We characterized further the kinetics of triiodothyronine (T3) and thyroxine (T4) binding and the biochemical properties of the nuclear receptor after extraction to a soluble form with 0.4 M KCl. In vitro binding of [125I]T3 and [125I]T4 with GH1 cell and rat liver nuclear extract was examined at 0°C and 37°C. Equilibrium was attained within 5 min at 37°C and 2 h at 0°C. The binding activity from GH1 cells was stable for at least 1 h at 37°C and 10 days at - 20°C. Chromatography on a weak carboxylic acid column and inactivation by trypsin and Pronase, but not by DNase or RNase, suggested that the putative receptor was a nonhistone protein. The estimated equilibrium dissociation constants (Kd) for hormone binding to the solubilized nuclear binding activity was 1.80 × 10-10 M (T3) and 1.20 × 10-9 M (T4) for GH1 cells and 1.57 × 10-10 M (T3) and 2.0 × 10-9 M (T4) for rat liver. These Kd values for T3 are virtually identical to those which we previously reported with isolated rat liver nuclei and GH1 cell nuclei in vitro.

The 10-fold greater affinity for T3 compared to T4 in the nuclear extract is also identical to that observed with intact GH1 cells. In addition, the [125I]T3 and [125I]T4 high-affinity binding in the nuclear extract were inhibited by either nonradioactive T3 or T4, which suggests that the binding activity in nuclear extract was identical for T3 and T4.

In contrast, the binding activity for T4 and T3 in GH1 cell cytosol was markedly different from that observed with nuclear extract (Kd values were 2.87 × 10-10 M for T4 and 1.13 × 10-9 M for T3).

Our results indicate that nuclear receptors for T3 and T4 can be isolated in a soluble and stable form with no apparent change in hormonal affinity. This should allow elucidation of the mechanisms of thyroid hormone action at the molecular level.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 853
page 853
icon of scanned page 854
page 854
icon of scanned page 855
page 855
icon of scanned page 856
page 856
icon of scanned page 857
page 857
icon of scanned page 858
page 858
icon of scanned page 859
page 859
icon of scanned page 860
page 860
icon of scanned page 861
page 861
icon of scanned page 862
page 862
icon of scanned page 863
page 863
icon of scanned page 864
page 864
icon of scanned page 865
page 865
Version history
  • Version 1 (October 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (169)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts